JACOBS LEVY EQUITY MANAGEMENT, INC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 884414
FLORHAM PARK, NJ
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,425,555
-$650,030 QoQ
Shares Held
1,213,326
+3.8% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#13
of 172 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. VNDA ranks #20 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in VNDA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,425,555 | 1,213,326 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,075,585 | 1,168,681 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,248,334 | 708,428 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $541,963 | 108,610 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $783,486 | 165,993 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,259,004 | 274,293 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,254,777 | 470,726 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,709,199 | 1,430,533 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,397,380 | 1,486,262 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,834,391 | 1,419,560 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,033,967 | 1,429,850 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,172,497 | 965,856 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $5,331,046 | 808,960 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,087,282 | 896,507 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,284,049 | 850,345 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,456,983 | 855,970 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $11,243,295 | 1,031,495 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $912,524 | 80,683 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $1,499,630 | 87,493 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,767,347 | 221,634 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,641,489 | 708,488 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,873,908 | 751,439 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 56,192 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $4,329,071 | 448,144 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 ALXN | — | 10,055 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||